Top Markets
Coin of the day
Nanexa AB (publ) Nanexa AB (publ)

Nanexa AB (publ)

NANEXA
Rank in Stocks #22470
Nanexa AB (publ) is a firm dedicated to developing advanced drug delivery... Nanexa AB (publ) is a firm dedicated to developing advanced drug delivery solutions through nanotechnology. The company leverages its proprietary PharmaShell platform, a nanobased system that utilizes atomic layer deposition (ALD) technology for drug administration. Furthermore, Nanexa is progressing NEX-18, a PharmaShell-based candidate specifically designed to address severe conditions such as Myelodysplastic Syndrome and Acute Myeloid Leukemia. The company was established in 2007 and is headquartered in Uppsala, Sweden.
Share Price
$0.53501203
Last synced: 2026-08-21
Market Cap
$88.05M
Change (1 day)
3.01%
Change (1 year)
128.79%
Country
SE
Trade Nanexa AB (publ) (NANEXA)

Category

Revenue for Nanexa AB (publ) (NANEXA)
Revenue in Aug 2026 TTM: 0
According to Nanexa AB (publ) latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Nanexa AB (publ) from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors